INDOUSBSEIndo Us Bio-Tech LtdMediumNeutral
Announced Tue, 16 Jun · 16:11 IST

Indo Us Bio-Tech Replaces Both Statutory and Internal Auditors

Auditor Resigned MidtermManagement Changes View source PDF

INDOUS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+5.9%1-day move
₹89.00
prior close
₹87.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+4.1+2.7+3.5+4.1+5.9+1.7+4.2+0.8+0.0+0.2+0.0-1.5
Up moveDown movePending
AI summary

Indo Us Bio-Tech replaced both its statutory auditor (M/s. Gautam N Associates, resigned 15-Jun-2026) and internal auditor (M/s. Raj Shah & Co, resigned 15-Jun-2026). M/s. Bhagat & Associates appointed as new statutory auditor from 16-Jun-2026, subject to shareholder approval. M/s. J.M. Raval & Co appointed as internal auditor for 5 years (FY26-27 to FY30-31). The outgoing statutory auditor cited administrative and operational restructuring of audit assignments. The new statutory auditor is based in Ahmedabad, near the company's registered office, replacing a Maharashtra-based firm.

Likely market impact

Auditor change tied to operational restructuring. New statutory auditor is local to Ahmedabad. Subject to shareholder approval.